NO180239C - Ekspresjonsvektor som koder for, og kan uttrykke et polypeptid med de biologiske og immunologiske egenskapene til EqIFN-<gamma>, vertsorganisme transformert med denne, og fremgangsmåte for fremstilling av nevnte polypeptid - Google Patents

Ekspresjonsvektor som koder for, og kan uttrykke et polypeptid med de biologiske og immunologiske egenskapene til EqIFN-<gamma>, vertsorganisme transformert med denne, og fremgangsmåte for fremstilling av nevnte polypeptid

Info

Publication number
NO180239C
NO180239C NO875136A NO875136A NO180239C NO 180239 C NO180239 C NO 180239C NO 875136 A NO875136 A NO 875136A NO 875136 A NO875136 A NO 875136A NO 180239 C NO180239 C NO 180239C
Authority
NO
Norway
Prior art keywords
polypeptide
gamma
eqifn
expressing
biological
Prior art date
Application number
NO875136A
Other languages
English (en)
Norwegian (no)
Other versions
NO180239B (no
NO875136L (no
NO875136D0 (no
Inventor
Rudolf Hauptmann
Adolf Himmler
Peter Swetly
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO875136D0 publication Critical patent/NO875136D0/no
Publication of NO875136L publication Critical patent/NO875136L/no
Publication of NO180239B publication Critical patent/NO180239B/no
Publication of NO180239C publication Critical patent/NO180239C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO875136A 1986-12-10 1987-12-09 Ekspresjonsvektor som koder for, og kan uttrykke et polypeptid med de biologiske og immunologiske egenskapene til EqIFN-<gamma>, vertsorganisme transformert med denne, og fremgangsmåte for fremstilling av nevnte polypeptid NO180239C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863642096 DE3642096A1 (de) 1986-12-10 1986-12-10 Pferde-(gamma)-interferon

Publications (4)

Publication Number Publication Date
NO875136D0 NO875136D0 (no) 1987-12-09
NO875136L NO875136L (no) 1988-06-13
NO180239B NO180239B (no) 1996-12-02
NO180239C true NO180239C (no) 1997-03-12

Family

ID=6315829

Family Applications (1)

Application Number Title Priority Date Filing Date
NO875136A NO180239C (no) 1986-12-10 1987-12-09 Ekspresjonsvektor som koder for, og kan uttrykke et polypeptid med de biologiske og immunologiske egenskapene til EqIFN-<gamma>, vertsorganisme transformert med denne, og fremgangsmåte for fremstilling av nevnte polypeptid

Country Status (20)

Country Link
US (1) US5602010A (xx)
EP (1) EP0271824B1 (xx)
JP (3) JPS63233794A (xx)
KR (1) KR880007568A (xx)
AT (1) ATE91722T1 (xx)
AU (1) AU616873B2 (xx)
CA (1) CA1339776C (xx)
DE (2) DE3642096A1 (xx)
DK (1) DK170054B1 (xx)
ES (1) ES2058094T3 (xx)
FI (1) FI99116C (xx)
HU (1) HU213566B (xx)
IE (1) IE60404B1 (xx)
IL (1) IL84780A (xx)
NO (1) NO180239C (xx)
NZ (1) NZ222856A (xx)
PH (1) PH30889A (xx)
PT (1) PT86332B (xx)
SU (1) SU1701114A3 (xx)
ZA (1) ZA879245B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE56471T1 (de) 1980-04-03 1990-09-15 Biogen Inc Dns-sequenzen, rekombinante dns-molekuele und verfahren zur herstellung von dem menschlichen fibroblast-interferon.
US6307025B1 (en) 1989-04-28 2001-10-23 Biogen, Inc. VCAM fusion proteins and DNA coding therefor
US5272263A (en) 1989-04-28 1993-12-21 Biogen, Inc. DNA sequences encoding vascular cell adhesion molecules (VCAMS)
US7049102B1 (en) 1989-09-22 2006-05-23 Board Of Trustees Of Leland Stanford University Multi-gene expression profile
GB9414752D0 (en) * 1994-07-21 1994-09-07 Q One Biotech Ltd Feline gamma-interferon
GB2291645A (en) * 1994-07-21 1996-01-31 Q One Biotech Ltd Equine gamma-interferon
AU2587002A (en) * 2000-11-03 2002-05-15 Biomedicines Inc Method for short-term and long-term drug dosimetry
EP1536839B1 (en) * 2001-11-09 2010-09-15 Intarcia Therapeutics, Inc Combination therapy comprising omega-interferon for treating infection with hepatitis c virus or yellow fever virus
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
AU2007266475B2 (en) 2006-05-30 2009-12-03 Intarcia Therapeutics, Inc. Two-piece, internal-channel osmotic delivery system flow modulator
DK2049081T3 (da) 2006-08-09 2013-02-25 Intarcia Therapeutics Inc Osmotiske leveringssystemer og stempelarrangementer
PT2157967E (pt) 2007-04-23 2013-04-03 Intarcia Therapeutics Inc Formulações de suspensões de péptidos insulinotrópicos e suas utilizações
DK2240155T3 (da) 2008-02-13 2012-09-17 Intarcia Therapeutics Inc Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
KR102148624B1 (ko) 2009-09-28 2020-08-26 인타르시아 세라퓨틱스 인코포레이티드 실질 항정상태 약물 전달의 신속 확립 및/또는 종결
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
KR20240042548A (ko) 2015-06-03 2024-04-02 인타르시아 세라퓨틱스 인코포레이티드 임플란트 배치 및 제거 시스템들
CN109310743A (zh) 2016-05-16 2019-02-05 因塔西亚制药公司 胰高血糖素受体选择性多肽及其使用方法
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
KR20190104039A (ko) 2017-01-03 2019-09-05 인타르시아 세라퓨틱스 인코포레이티드 Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE88622C (xx) *
ZA811368B (en) * 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
ZA831094B (en) * 1982-02-22 1983-11-30 Biogen Nv Dna sequences,recombinant dna molecules and processes for producing human immune interferon-like polypeptides
IE54592B1 (en) * 1982-03-08 1989-12-06 Genentech Inc Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby
DE3247922A1 (de) * 1982-12-24 1984-06-28 Boehringer Ingelheim International GmbH, 6507 Ingelheim Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
JPS60118196A (ja) * 1983-11-30 1985-06-25 Takeda Chem Ind Ltd インタ−フェロンの製造法
US4666865A (en) * 1984-01-13 1987-05-19 Centocor, Inc. Immunoassay for biologically active human interferon-gamma employing unique monoclonal antibodies
DE3414831A1 (de) * 1984-04-19 1985-10-31 Hoechst Ag, 6230 Frankfurt Herstellung von polypeptiden mit human-gammainterferon-aktivitaet
FI90990C (fi) * 1984-12-18 1994-04-25 Boehringer Ingelheim Int Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
US4689224A (en) * 1985-10-07 1987-08-25 Neogen Corporation Method for administering vaccines containing equine leukokines and compositions therefor
DE3607835A1 (de) * 1986-03-10 1987-09-24 Boehringer Ingelheim Int Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
CA1340698C (en) * 1986-07-25 1999-08-10 Kabushiki Kaisha Hayashibara Seibutsu Kaguku Kenkyujo Preparation and uses of interferon-gamma
US4908432A (en) * 1987-01-09 1990-03-13 New York University Novel polypeptide having gamma-interferon activity

Also Published As

Publication number Publication date
PH30889A (en) 1997-12-23
NO180239B (no) 1996-12-02
IL84780A (en) 1992-11-15
IE60404B1 (en) 1994-07-13
NO875136L (no) 1988-06-13
EP0271824A3 (en) 1989-05-24
IE873342L (en) 1988-06-10
FI99116B (fi) 1997-06-30
CA1339776C (en) 1998-03-24
US5602010A (en) 1997-02-11
DE3786649D1 (de) 1993-08-26
HU213566B (en) 1997-08-28
EP0271824B1 (de) 1993-07-21
PT86332B (pt) 1990-11-07
FI875427A0 (fi) 1987-12-10
SU1701114A3 (ru) 1991-12-23
DK170054B1 (da) 1995-05-08
NO875136D0 (no) 1987-12-09
JPS63233794A (ja) 1988-09-29
FI99116C (fi) 1997-10-10
ATE91722T1 (de) 1993-08-15
DK645887A (da) 1988-06-11
PT86332A (de) 1988-01-01
AU616873B2 (en) 1991-11-14
ZA879245B (en) 1989-08-30
EP0271824A2 (de) 1988-06-22
NZ222856A (en) 1991-11-26
JPH07250690A (ja) 1995-10-03
AU8223387A (en) 1988-06-30
JPH07258294A (ja) 1995-10-09
FI875427A (fi) 1988-06-11
DE3642096A1 (de) 1988-06-16
DK645887D0 (da) 1987-12-09
KR880007568A (ko) 1988-08-27
HUT46066A (en) 1988-09-28
IL84780A0 (en) 1988-05-31
ES2058094T3 (es) 1994-11-01

Similar Documents

Publication Publication Date Title
NO180239C (no) Ekspresjonsvektor som koder for, og kan uttrykke et polypeptid med de biologiske og immunologiske egenskapene til EqIFN-&lt;gamma&gt;, vertsorganisme transformert med denne, og fremgangsmåte for fremstilling av nevnte polypeptid
DE3586189D1 (de) Menge und verfahren zur herstellung rekombinierter erzeugnisse in grosser ausbeute.
YU193887A (en) PROCESS FOR OBTAINING APOLYPOPROTEINE &#34;Al&#34;
DE69433690D1 (de) Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
DK491487A (da) Dna-sekvens til ekspressionering af biologisk aktivt faktor xiii og anvendelse af samme
CA2066370A1 (en) Yield when disulfide-bonded proteins are secreted
DK611386A (da) Recombinant humant fsh, fremgangsmaade til fremstilling deraf og vektorer og celler til anvendelse ved fremgangsmaaden
DK1520860T3 (da) Rekombinant protein PilC, fremgangsmåde til dets fremstilling og anvendelse deraf
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
SE8601940D0 (sv) Preparation of fused proteins, antibodies and processes therefor
DK595187D0 (da) Minactivin og fremgangsmaade til fremstilling deraf
IL82962A0 (en) Dna sequences containing a light inducible promoter derived from a myxobacterium and process for preparing polypeptides
DE3877136D1 (de) Rekombinantes histidinreiches protein von plasmodium falciparum, seine herstellung und verwendung.
DK1241186T3 (da) Humant vækststandsende specifikt gen-6 (gas-6) og nukleinsyrer kodende derfor
DE3876227D1 (de) Malaria-spezifische dna-sequenzen, ihre expressionsprodukte und deren verwendung.
DK1241251T3 (da) Humant prostasin-lignende protein og nukleinsyrer kodende for samme
DK1241183T3 (da) Humant HCAR-agtig protein og nucleinsyrer kodende derfor